flucytosine has been researched along with Central Nervous System Diseases in 10 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Results obtained in the treatment of cryptococcosis of the central nervous system with amphotericin-B, 5-fluorocytosine and miconazole are evaluated." | 7.66 | [Cryptococcosis of the central nervous system: evaluation of amphotericin-B, 5-fluorocytosine and miconazole therapy in 18 cases]. ( Livramento, JA; Machado, LR; Nobrega, JP; Spina-França, A, 1979) |
| "The drugs used in the treatment of CNS cryptococcosis were, as possible, the amphotericin B by intravenous and intrathecal route (lumbar puncture) associated with 5-fluorocytosine." | 5.27 | [Amphotericin B in the treatment of neurocryptococcosis in patients subjected to renal transplantation]. ( Nóbrega, JP, 1988) |
| "Results obtained in the treatment of cryptococcosis of the central nervous system with amphotericin-B, 5-fluorocytosine and miconazole are evaluated." | 3.66 | [Cryptococcosis of the central nervous system: evaluation of amphotericin-B, 5-fluorocytosine and miconazole therapy in 18 cases]. ( Livramento, JA; Machado, LR; Nobrega, JP; Spina-França, A, 1979) |
| "Amphotericin B has remained the most effective therapeutic preparation for most types of neurological fungal disease, although important roles for 5-fluorocytosine, miconazole, and, more recently, ketoconazole are being recognized." | 2.36 | Treatment of fungal infections of the central nervous system. ( Bell, WE, 1981) |
| "Treatment with fluconazole is only recommended for localised pulmonary disease." | 1.62 | Treatment and mortality outcomes in patients with other extrapulmonary cryptococcal disease compared with central nervous system disease. ( Larson, L; Mejia-Chew, C; Powderly, WG; Spec, A; Sung, A, 2021) |
| "The drugs used in the treatment of CNS cryptococcosis were, as possible, the amphotericin B by intravenous and intrathecal route (lumbar puncture) associated with 5-fluorocytosine." | 1.27 | [Amphotericin B in the treatment of neurocryptococcosis in patients subjected to renal transplantation]. ( Nóbrega, JP, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (90.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mejia-Chew, C | 1 |
| Sung, A | 1 |
| Larson, L | 1 |
| Powderly, WG | 1 |
| Spec, A | 1 |
| Faix, RG | 1 |
| Bell, WE | 1 |
| Fujita, N | 1 |
| Grinnell, V | 1 |
| Edwards, JE | 1 |
| Feldman, RA | 1 |
| Nobrega, JP | 2 |
| Livramento, JA | 1 |
| Machado, LR | 1 |
| Spina-França, A | 1 |
| Cochius, JI | 1 |
| Burns, RJ | 1 |
| Willoughby, JO | 1 |
| Scholer, HJ | 1 |
| Sabetta, JR | 1 |
| Andriole, VT | 1 |
| Neuhaus, F | 1 |
| Seeliger, H | 1 |
| Tympner, KD | 1 |
| Tümbay, E | 1 |
2 reviews available for flucytosine and Central Nervous System Diseases
| Article | Year |
|---|---|
Treatment of fungal infections of the central nervous system.
Topics: Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Chemical Phenomena; Chemistry; F | 1981 |
Diagnosis of cryptococcosis and monitoring of chemotherapy.
Topics: Adolescent; Adult; Africa; Amphotericin B; Asia, Southeastern; Australia; Central Nervous System Dis | 1985 |
8 other studies available for flucytosine and Central Nervous System Diseases
| Article | Year |
|---|---|
Treatment and mortality outcomes in patients with other extrapulmonary cryptococcal disease compared with central nervous system disease.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Cryptococcosis; Cry | 2021 |
Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement.
Topics: Amphotericin B; Candidiasis; Central Nervous System Diseases; Female; Flucytosine; Humans; Infant; I | 1984 |
Management of central nervous system cryptococcosis.
Topics: Amphotericin B; Brain Diseases; Central Nervous System Diseases; Cryptococcosis; Flucytosine; Humans | 1980 |
[Cryptococcosis of the central nervous system: evaluation of amphotericin-B, 5-fluorocytosine and miconazole therapy in 18 cases].
Topics: Adolescent; Adult; Amphotericin B; Central Nervous System Diseases; Child, Preschool; Cryptococcosis | 1979 |
CNS cryptococcosis: unusual aspects.
Topics: Adult; Aged; Amphotericin B; Central Nervous System Diseases; Cryptococcosis; Female; Fluconazole; F | 1989 |
[Amphotericin B in the treatment of neurocryptococcosis in patients subjected to renal transplantation].
Topics: Adolescent; Adult; Aged; Amphotericin B; Central Nervous System Diseases; Child; Child, Preschool; C | 1988 |
Cryptococcal infection of the central nervous system.
Topics: Amphotericin B; Central Nervous System Diseases; Cryptococcosis; Flucytosine; Humans; Meningitis; Pr | 1985 |
[Cryptococcosis of the central nervous system with cellular immune reaction disorders].
Topics: Antifungal Agents; Benzene Derivatives; Central Nervous System Diseases; Child; Cryptococcosis; Fema | 1974 |